The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -2.04 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M -3.18 — no flag raisedOK
- Earnings quality 82/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as CRYO CELL INTERNATIONAL INC reports it. History and quarterly detail are in the app.
- Umbilical Cord Blood And Cord Tissue Stem Cell Service$31.4M
- Public Cord Blood Banking$130K
- Prepacytecb$54K
Latest filings
- 8-K · Company announcement2026-05-08
- 10-Q · Quarterly report2026-04-14
- 8-K · Company announcement2026-03-12
- 10-K · Annual report2026-02-27
- 8-K · Company announcement2025-11-12
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about CRYO CELL INTERNATIONAL INC, every answer cited🔒
- The Intelligence Brief — added when CRYO CELL INTERNATIONAL INC's brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.